Global Inflammatory Bowel Disease Drugs Market Professional Survey Report 2016
- QYR577402
- 111 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
The segment applications including
Segment regions including (the separated region report can also be offered)
USA
China
Europe
South America
Japan
Africa
The players list (Partly, Players you are interested in can also be added)
Merck & Company
Janssen Pharmaceuticals
Abbvie
Biogen Idec
UCB
Shire
Pfizer
Novartis
Novo Nordisk
Boehringer Ingelheim
Salix Pharmaceuticals
Genentech
Amgen
Mitsubishi Tanabe
Akebia Therapeutics
Celltrion
ChemoCentryx
Ferring Pharmaceuticals
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - K Doses and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Inflammatory Bowel Disease Drugs
1.1 Definition and Specifications of Inflammatory Bowel Disease Drugs
1.1.1 Definition of Inflammatory Bowel Disease Drugs
1.1.2 Specifications of Inflammatory Bowel Disease Drugs
1.2 Classification of Inflammatory Bowel Disease Drugs
1.3 Applications of Inflammatory Bowel Disease Drugs
1.4 Industry Chain Structure of Inflammatory Bowel Disease Drugs
1.5 Industry Overview and Major Regions Status of Inflammatory Bowel Disease Drugs
1.5.1 Industry Overview of Inflammatory Bowel Disease Drugs
1.5.2 Global Major Regions Status of Inflammatory Bowel Disease Drugs
1.6 Industry Policy Analysis of Inflammatory Bowel Disease Drugs
1.7 Industry News Analysis of Inflammatory Bowel Disease Drugs
2 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs
2.1 Raw Material Suppliers and Price Analysis of Inflammatory Bowel Disease Drugs
2.2 Equipment Suppliers and Price Analysis of Inflammatory Bowel Disease Drugs
2.3 Labor Cost Analysis of Inflammatory Bowel Disease Drugs
2.4 Other Costs Analysis of Inflammatory Bowel Disease Drugs
2.5 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs
2.6 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
3 Technical Data and Manufacturing Plants Analysis of Inflammatory Bowel Disease Drugs
3.1 Capacity and Commercial Production Date of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
4 Global Inflammatory Bowel Disease Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Inflammatory Bowel Disease Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Inflammatory Bowel Disease Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Inflammatory Bowel Disease Drugs Sales and Growth Rate Analysis
4.3.2 2015 Inflammatory Bowel Disease Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Inflammatory Bowel Disease Drugs Sales Price
4.4.2 2015 Inflammatory Bowel Disease Drugs Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Inflammatory Bowel Disease Drugs Gross Margin
4.5.2 2015 Inflammatory Bowel Disease Drugs Gross Margin Analysis (Company Segment)
5 Inflammatory Bowel Disease Drugs Regional Market Analysis
5.1 USA Inflammatory Bowel Disease Drugs Market Analysis
5.1.1 USA Inflammatory Bowel Disease Drugs Market Overview
5.1.2 USA 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.1.4 USA 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.2 China Inflammatory Bowel Disease Drugs Market Analysis
5.2.1 China Inflammatory Bowel Disease Drugs Market Overview
5.2.2 China 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.2.4 China 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.3 Europe Inflammatory Bowel Disease Drugs Market Analysis
5.3.1 Europe Inflammatory Bowel Disease Drugs Market Overview
5.3.2 Europe 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.3.4 Europe 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.4 South America Inflammatory Bowel Disease Drugs Market Analysis
5.4.1 South America Inflammatory Bowel Disease Drugs Market Overview
5.4.2 South America 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 South America 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.4.4 South America 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.5 Japan Inflammatory Bowel Disease Drugs Market Analysis
5.5.1 Japan Inflammatory Bowel Disease Drugs Market Overview
5.5.2 Japan 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.5.4 Japan 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.6 Africa Inflammatory Bowel Disease Drugs Market Analysis
5.6.1 Africa Inflammatory Bowel Disease Drugs Market Overview
5.6.2 Africa 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Africa 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.6.4 Africa 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
6 Global 2011-2016E Inflammatory Bowel Disease Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Inflammatory Bowel Disease Drugs Sales by Type
6.2 Different Types Inflammatory Bowel Disease Drugs Product Interview Price Analysis
6.3 Different Types Inflammatory Bowel Disease Drugs Product Driving Factors Analysis
7 Global 2011-2016E Inflammatory Bowel Disease Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 Major Manufacturers Analysis of Inflammatory Bowel Disease Drugs
8.1 Merck & Company
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Merck & Company 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck & Company 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.2 Janssen Pharmaceuticals
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Janssen Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Janssen Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.3 Abbvie
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Abbvie 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Abbvie 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.4 Biogen Idec
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Biogen Idec 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Biogen Idec 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.5 UCB
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 UCB 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 UCB 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.6 Shire
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Shire 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Shire 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Pfizer 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.8 Novartis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Novartis 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Novartis 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.9 Novo Nordisk
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Novo Nordisk 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Novo Nordisk 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.10 Boehringer Ingelheim
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Boehringer Ingelheim 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Boehringer Ingelheim 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.11 Salix Pharmaceuticals
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Salix Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Salix Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.12 Genentech
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Genentech 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Genentech 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.13 Amgen
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Amgen 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Amgen 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.14 Mitsubishi Tanabe
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Mitsubishi Tanabe 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Mitsubishi Tanabe 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.15 Akebia Therapeutics
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Akebia Therapeutics 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Akebia Therapeutics 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.16 Celltrion
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Celltrion 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Celltrion 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.17 ChemoCentryx
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 ChemoCentryx 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 ChemoCentryx 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.18 Ferring Pharmaceuticals
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Ferring Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Ferring Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.2 China 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.3 Europe 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.4 South America 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.5 Japan 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.6 Africa 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Inflammatory Bowel Disease Drugs Marketing Model Analysis
10.1 Inflammatory Bowel Disease Drugs Regional Marketing Model Analysis
10.2 Inflammatory Bowel Disease Drugs International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Inflammatory Bowel Disease Drugs by Regions
10.4 Inflammatory Bowel Disease Drugs Supply Chain Analysis
11 Consumers Analysis of Inflammatory Bowel Disease Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Inflammatory Bowel Disease Drugs
12.1 New Project SWOT Analysis of Inflammatory Bowel Disease Drugs
12.2 New Project Investment Feasibility Analysis of Inflammatory Bowel Disease Drugs
13 Conclusion of the Global Inflammatory Bowel Disease Drugs Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
